About the Anticancer Drugs Session
Anticancer drugs play a crucial role in the fight against cancer, targeting and eliminating malignant cells while sparing healthy tissue. Recent advancements in cancer research have led to the development of more precise and effective treatments, such as targeted therapies and immunotherapies. Targeted therapies focus on specific molecular alterations in cancer cells, offering a personalized approach to treatment. Immunotherapies harness the power of the body's immune system to recognize and attack cancer cells, providing long-lasting responses and reduced side effects compared to traditional chemotherapy. Additionally, combination therapies, which use multiple anticancer agents, have shown promise in overcoming drug resistance and improving patient outcomes. Continuous research and clinical trials are essential to discover novel drugs and optimize existing treatments, offering hope for more effective cancer management and improved survival rates.
Topics Covered in Anticancer Drugs
Mechanisms of Action
Drug Resistance Pathways
Dose-Limiting Toxicity
Drug-Drug Interactions
Immune Checkpoint Blockade
Hormone Therapies
Related Scientific Sessions at CIOC 2027
Why Attend the Anticancer Drugs Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Anticancer Drugs work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Anticancer Drugs research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Anticancer Drugs track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Anticancer Drugs Conference 2027 — FAQs
What is the Anticancer Drugs track at CIOC 2027?
The Anticancer Drugs track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Anticancer Drugs. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Anticancer Drugs sessions?
Cancer researchers and clinicians, educators and students with an interest in Anticancer Drugs are all welcome — whether presenting or attending.
Can I present my research in the Anticancer Drugs track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Anticancer Drugs sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Anticancer Drugs track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.